Summary of opinion: MenQuadfi, 25/06/2026 Positive
Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
Summary of opinion: MenQuadfi, 25/06/2026 Positive
Summary of opinion: Rinvoq, 25/06/2026 Positive
Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
Summary of opinion: Rinvoq, 25/06/2026 Positive
Summary of opinion: Tecvayli, 25/05/2026 Positive
Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
Summary of opinion: Tecvayli, 25/05/2026 Positive
EMA recommends revoking marketing authorisation for Tavneos
Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
EMA recommends revoking marketing authorisation for Tavneos
Referral: Tavneos, avacopan Article 20 procedures CHMP opinion, 25/06/2026, 26/06/2026
Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
Referral: Tavneos, avacopan Article 20 procedures CHMP opinion, 25/06/2026, 26/06/2026
Summary of opinion: Rezolsta, 25/06/2026 Positive
Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
Summary of opinion: Rezolsta, 25/06/2026 Positive
Summary of opinion: Jaypirca, 25/06/2026 Positive
Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
Summary of opinion: Jaypirca, 25/06/2026 Positive
Summary of opinion: Rinvoq, 25/06/2026 Positive
Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
Summary of opinion: Rinvoq, 25/06/2026 Positive
Summary of opinion: Imvanex, 25/06/2026 Positive
Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
Summary of opinion: Imvanex, 25/06/2026 Positive
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 20, Status: Authorised
Submitted by Anonymous (not verified) on 26 June 2026 - 11:00
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 20, Status: Authorised